Is it worth accessing medical tech stocks via crowdfunding?

Is it worth accessing medical tech stocks via crowdfunding?

Goncalo de Vasconcelos, CEO of equity funding platform SyndicateRoom, explains how investors can gain exposure to smaller companies developing medical innovations via crowdfunding.

Medical technology is the investment story of the moment. It is 15 years since the ‘eureka’ moment when the entire human genome was mapped for the first time, and the practical applications made possible by that work are transforming people’s lives. It took time to commercialise genomics and related technologies, but the scale of the opportunity is now unprecedented. To see why, consider the $3bn cost of that first mapping project. Today, by contrast, table-top gene sequencing equipment that does the same job costs less than $1,000. At that cost, even the most small-scale ventures (sp...